<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
85945-0001-2
</NDCCode>
<PackageDescription>
8 U in 1 PATCH (85945-0001-2)
</PackageDescription>
<NDC11Code>
85945-0001-02
</NDC11Code>
<ProductNDC>
85945-0001
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Converthera Nad Plus Patch
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Converthera Nad Plus Patch
</NonProprietaryName>
<DosageFormName>
PATCH
</DosageFormName>
<RouteName>
TRANSDERMAL
</RouteName>
<StartMarketingDate>
20250701
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
UNAPPROVED DRUG OTHER
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Through Medical INC.
</LabelerName>
<SubstanceName>
GLUTATHIONE; NICOTINAMIDE ADENINE DINUCLEOTIDE
</SubstanceName>
<StrengthNumber>
25; 250
</StrengthNumber>
<StrengthUnit>
mg/U; mg/U
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2025-07-22
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20250701
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>